Net debt cut $4.9m on stronger cash but PBT flat at $8.6m

This means the headline earnings growth is tax-driven; PBT is the cleaner read on the operating result and it did not move.

The cash and balance sheet movements are larger. Operating cash flow rose 35% to $13.2m, free cash flow was $7.6m, and gross borrowings fell from $11.9m to $8.5m. Net debt declined from $11.8m to $6.9m, a $4.9m reduction. The full-year dividend stepped up to 1.5cps (final 0.85cps plus interim) from 0.5cps in FY24, with the company-disclosed payout ratio at 58% of NPAT.

Capital raise adds balance-sheet context, with NZ$20m capital raised, but borrowings and gearing are the direct leverage evidence.

PBT was unchanged year-on-year, and the 340bp drop in the effective tax rate explains essentially all of the +6.7% NPAT growth. For an investor, this means the underlying earnings engine did not grow in FY25; the cleaner operating read is flat, not up mid-single-digit.

Cash generation outran reported earnings. OCF/EBITDA of 82.2% and FCF/NPAT of 119.7% indicate cash conversion is materially better than the income statement suggests, helped by lower capex ($3.2m vs $3.8m) and a small working-capital release. This is what funded the $4.9m debt paydown and the higher distribution, and it is the most economically material change in the period.

Capital allocation shift, on a still-weak ROE. The full-year dividend tripled and the NPAT payout ratio doubled from 25.0% to 50.0%, yet ROE of 9.3% sits at the lower edge of Annolyse's historical range (mean 11.9%). Higher distributions on a softer return profile narrow the margin for reinvestment if H2 normalised revenue growth does not extend.

The interim split shows HY25 was 50.7% of full-year revenue, 48.4% of EBITDA and 46.5% of NPAT, so the business is modestly second-half weighted on profit but close to even on the top line. Management commentary points to 5% normalised H2 revenue growth, implying the FY25 flat headline is a function of comparability rather than full-year run-rate weakness.

What the release does not support is any extrapolation of NPAT growth: the comparable run-rate is flat-to-slightly-positive at the PBT line, and the tax tailwind is unlikely to repeat at the same magnitude.

Free cash flow of $7.6m exceeded NPAT, capex intensity fell to 2.0% of revenue, and the working-capital movement was -$0.1m (a small release). Inventory days at 0.9 sit below Annolyse's historical baseline range (3-period mean 3.6 days), and debtor days at 0.7 are at the lower edge of the historical range — both favourable, but the inventory position is unusually low and a partial reversion would absorb cash next period.

Earnings quality is more mixed. PBT growth of 0.0% is at the upper edge of the company's recent historical range (3-period mean -41.3%), which says FY25 has stabilised relative to a poor run, not that it is expanding. The NPAT margin of 3.9% sits at the lower edge of the historical range despite the tax tailwind. Read together, the durable element of this result is the deleveraging and cash conversion; the NPAT growth line itself is not a durable earnings signal.

This briefing cannot assess customer-cohort retention, gross margin progression, or category-level mix because gross margin movement, segment data and active-customer disclosures were not provided in the supplied materials.